glp 1 pancreatic cancer Frontiers glp-1 pancreatic cancer Risk of

Constant exposure can downregulate these receptors, requiring higher doses for the same effect

GLP-1 agonist tirzepatide and oral contraceptives The UKs MHRA recently issued guidance reminding patients using the GLP-1 agonist tirzepatide, who are also on oral contraceptives, that a barrier form of contraception should also be used

Haberle, J

doi: 10.1056/nejmoa2107519, 20

The most common risks associated with Liposuction are subtle cosmetic differences, such as contour defects or asymmetry, rippling or dimpling of the skin, or the appearance of grooves

Guidance on the use of recreational cannabis for type 1 diabetes and those with other forms of diabetes at risk for diabetic ketoacidosis (DKA)